A new clinical trial from Flinders University reveals that quetiapine, often used off-label to improve sleep, can significantly slow reaction times and reduce driving performance the following day, posing safety concerns despite its benefits in enhancing sleep quality.
- Quetiapine improves sleep but impairs next-day reaction and driving ability.
- The drug’s off-label use for sleep disorders lacks strong safety data.
- Many users may underestimate lingering effects, increasing accident risk.
What happened
A randomized, double-blind, placebo-controlled trial led by Flinders University involved 15 adults who received 50 mg of quetiapine on one night and a placebo on another. Researchers monitored their sleep and next-day functioning using a driving simulator and cognitive tests. The study confirmed that quetiapine helped participants sleep longer and reduced nighttime breathing interruptions associated with obstructive sleep apnea.
However, the mornings following quetiapine use revealed slower reaction times, impaired attention, and decreased steering control in simulated driving. Some participants showed physical side effects such as dizziness and blood-pressure drops, with one person requiring a medical evaluation after a fall. These findings provide important insights into the unintended consequences of quetiapine when used for sleep.
Why it feels good
Quetiapine’s use as an alternative to more addictive sleep medications like benzodiazepines has grown because it is perceived as a safer option for managing insomnia or sleep apnea symptoms. Its ability to improve sleep continuity and reduce awakenings might offer immediate relief to those struggling with disturbed sleep patterns.
Improved nighttime breathing and longer sleep duration can positively affect overall well-being, especially for individuals unaware they have obstructive sleep apnea—a condition affecting up to 20% of adults. Addressing sleep interruptions can enhance restfulness, which people naturally desire and value for everyday functioning.
What to enjoy or watch next
This study opens the door to future larger clinical trials needed to thoroughly evaluate quetiapine’s safety profile when prescribed for sleep disorders. Clinicians and patients should remain cautious about off-label quetiapine use until further evidence clarifies risks versus benefits, especially for activities demanding alertness like driving.
Meanwhile, those experiencing insomnia or suspected sleep apnea might explore comprehensive sleep assessments and alternative therapies under medical guidance. Staying informed about medication effects and discussing concerns with healthcare professionals can help individuals find safer, more effective ways to improve their sleep and daytime functioning.